You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Sleep and sleep conditions

Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia

  • Technology appraisal guidance
  • Reference number: TA77
  • Published:  28 April 2004
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix 1

  • Actavis

  • British Sleep Society

  • Counsel and Care

  • Department of Health

  • Dowelhurst Ltd

  • NHS Quality Improvement Scotland

  • Pfizer Ltd

  • Royal College of Nursing

  • Rosemont Pharmaceuticals

  • Sandoz Ltd

  • Teva UK

  • Wyeth Pharmaceuticals


This page was last updated: 30 March 2010

Back to top